Uddeling 2018

 
Dansk Kræftforskningsfonds uddeling 2018: 3.989.000 kr

Miss Karolin Voßgröne, BRIC
Projekt: Unravelling new tumor suppressor candidates through functional screening
Tildelt: 250.000 kr.

Dr Rune Hasselager, Zealand University Hospital Roskilde og Køge
Projekt: Impact of volatile inhalational anaesthesia, corticosteroids and regional nerve blocks on cancer recurrence in patients undergoing surgery for colorectal cancer: A Danish Population Based Cohort Study
Tildelt: 250.000 kr.

Miss Laura Toussaint, Aarhus University Hospital
Projekt: Reducing cognitive impairments following cranial irradiation of childhood cancer through the use of proton therapy
Tildelt: 250.000 kr.

Dr Marie Louise Holm Milo, Aarhus
Projekt: The risk of radiotherapy induced heart disease in women treated for early stage breast cancer
Tildelt: 250.000 kr.

Ms Lise Ahlborn, Rigshospitalet
Projekt: Non-invasive monitoring of personalized cancer treatment using circulating tumor DNA
Tildelt: 250.000 kr.

Dr Christina Marie Schiøttz Hassing, Rigshospitalet
Projekt: Adjuvant treatment of breast tumours ≤ 10 mm – do we offer the appropriate treatment?
Tildelt: 250.000 kr.

Ms Nadia Øgaard, Aarhus University Hospital
Projekt: Implementing blood-based DNA methylation markers for improved postoperative management of colorectal cancer patients
Tildelt: 248.000 kr.

Ms Sara Ambjørn, University of Copenhagen
Projekt: Consequences of BRCA2 breast cancer patient mutations
Tildelt: 234.000 kr.

Mrs Trine Strandgaard, Aarhus University Hospital
Projekt: Comprehensive analysis of the tumor ecosystem and adjacent normal tissue cancerization for predicting response to BCG immunotherapy in bladder cancer
Tildelt: 225.000 kr.

Dr Jannie Dressler, Bispebjerg Hospital
Projekt: Patient Compliance, Treatment Strategy, Morbidity and Health Related Resources associated with the Danish Colorectal Cancer Screening Program
Tildelt: 225.000 kr.

Miss Mahak Fatima, University of Copenhagen
Projekt: Establishing RABGAP1L-NTRK1 as Novel Driver and Drug Target in Liver Cancer
Tildelt: 225.000 kr.

Mr Emil Thomsen, Aarhus University
Projekt: Combinatorial genome-wide CRISPR screens for identification of gene networks controlling drug resistance in B cell lymphoma
Tildelt: 111.000 kr.

Mr Andreas Engel Krag, Aarhus University Hospital
Projekt: Ny behandling ved rekonstruktion efter cancerkirurgi
Tildelt: 111.000 kr.

Ms Camilla Nielsen, Aarhus University
Projekt: Going viral with oncolytic therapy: an alternative approach to Nrf2-mediated STING impairment in chemoresistant cancer cells
Tildelt: 111.000 kr.

Dr Mads Jochumsen, Aarhus University Hospital
Projekt: Non-invasiv måling af tumorperfusion med 82Rb PET i prostata
Tildelt: 111.000 kr.

Mr Jesper Pedersen, Aarhus University
Projekt: Improved immunotherapy of metastatic melanoma
Tildelt: 111.000 kr.

Dr. Liv Andrés-Jensen, Rigshospitalet
Projekt: Acute Lymphoblastic Leukemia Survivor Toxicity And Rehabilitation (ALL-STAR) Study
Tildelt: 111.000 kr.

Dr Elisabeth Tolley, Herlev Hospital
Projekt: Circulating cell-free tumor DNA and metabolites in cerebrospinal fluid as early biomarkers of secondary CNS involvement in diffuse large B-cell lymphoma
Tildelt: 111.000 kr.

Dr Thomas Buus, Aarhus University Hospital
Projekt: Whole Body MRI for Monitoring Bone Metastasizing Breast Cancer
Tildelt: 111.000 kr.

Mrs Maibritt Nørgaard, Aarhus University
Projekt: Deep sequencing of circulating tumor DNA (ctDNA) for prediction and monitoring of enzalutamide treatment response in castration resistant prostate cancer (CRPC)
Tildelt: 111.000 kr.

Dr Thomas Wagner Nielsen, Zealand University Hospital, Roskilde
Projekt: Prognostic factors for relapse in patients with clinical stage I testicular cancer
Tildelt: 111.000 kr.

Mr Jorne Biccler, Aalborg University Hospital
Projekt: Survival of Hodgkin and primary central nervous system lymphoma patients: describing the evolution of the relative survival and prognostic outlook
Tildelt: 111.000 kr.

Dr Mads Sandahl, Aarhus University Hospital
Projekt: Radiological prerequisites for early and accurate detection of prostate cancer in general practice
Tildelt: 111.000 kr.